---
title: "Director Robert J. Gould Reports Sale of Fulcrum Therapeutics Inc. Common Shares"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274867218.md"
datetime: "2026-02-04T21:10:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274867218.md)
  - [en](https://longbridge.com/en/news/274867218.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274867218.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274867218.md) | [繁體中文](https://longbridge.com/zh-HK/news/274867218.md)


# Director Robert J. Gould Reports Sale of Fulcrum Therapeutics Inc. Common Shares

Robert J. Gould, Director of Fulcrum Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-037573), on February 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相关股票

- [Fulcrum Therapeutics (FULC.US)](https://longbridge.com/zh-CN/quote/FULC.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-CN/quote/IXJ.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-CN/quote/VHT.US.md)

## 相关资讯与研究

- [Galecto Rebrands as Damora Therapeutics with New Ticker](https://longbridge.com/zh-CN/news/278556054.md)
- [CSP International Publishes Disclosure on V2D Création Acquisition](https://longbridge.com/zh-CN/news/278778570.md)
- [Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend](https://longbridge.com/zh-CN/news/279032442.md)
- [Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma](https://longbridge.com/zh-CN/news/279027875.md)
- [Vertex's kidney disease drug meets main goal in late-stage trial](https://longbridge.com/zh-CN/news/278442392.md)